Osler Diagnostics: Funding, Investors & Team (Oct 2026)
A UK-based diagnostics business called Osler wants to make it possible for anybody, anywhere to access, comprehend, and take control of their health in order to live longer, healthier lives. A "portable lab" that can offer lab-quality diagnostics to anyone, anywhere, at any time, Osler has created the Osler Origin. The Osler Origin will provide a broad range of diagnostic tests and support all significant worldwide healthcare environments. Following decades of study from the same department that created the portable electrochemical blood glucose monitor, Osler was established out of the University of Oxford in 2017. The Company is based in Oxford, United Kingdom.
Osler Diagnostics has raised $85.0M across 1 funding round on record, the most recent a Series C of $85.0M announced in Nov 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Osler Diagnostics Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Osler Diagnostics Funding Rounds
Osler Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Osler Diagnostics Funding Compared to Other Biotechnology Startups
Osler Diagnostics' latest round of $85.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Osler Diagnostics in Biotechnology and Oxford
Companies Similar to Osler Diagnostics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Osler Diagnostics Funding FAQs
What does Osler Diagnostics do?
A UK-based diagnostics business called Osler wants to make it possible for anybody, anywhere to access, comprehend, and take control of their health in order to live longer, healthier lives. A "portable lab" that can offer lab-quality diagnostics to anyone, anywhere, at any time, Osler has created the Osler Origin. The Osler Origin will provide a broad range of diagnostic tests and support all significant worldwide healthcare environments. Following decades of study from the same department that created the portable electrochemical blood glucose monitor, Osler was established out of the University of Oxford in 2017. The Company is based in Oxford, United Kingdom.
How much funding has Osler Diagnostics raised?
Osler Diagnostics has raised $85.0M across 1 round on record. The most recent is a Series C of $85.0M announced in Nov 2022.
When did Osler Diagnostics last raise funding?
Osler Diagnostics' most recent funding round on record is a Series C of $85.0M, announced in Nov 2022.
Who is the CEO of Osler Diagnostics?
Connor Campbell is listed as CEO at Osler Diagnostics.
Where is Osler Diagnostics headquartered?
Osler Diagnostics is based in Oxford, Oxfordshire, United Kingdom.
How many employees does Osler Diagnostics have?
Osler Diagnostics is in the 101-250 employee band.
How does Osler Diagnostics' funding compare to other Biotechnology startups?
Osler Diagnostics' latest round of $85.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Osler Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Osler Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.